Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG.

Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang RW, Dickinson M, Ng A, Roberts KB, Gao S, Balogh AG, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis S, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani R, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT.

Blood. 2020 Mar 25. pii: blood.2019003877. doi: 10.1182/blood.2019003877. [Epub ahead of print]

PMID:
32211877
2.

New Paradigm for Radiation in Multiple Myeloma: lower yet effective dose to avoid radiation toxicity.

Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, Thomas S, Iyer S, Kaufmann G, Garg N, Dabaja BS.

Haematologica. 2020 Jan 9. pii: haematol.2019.235804. doi: 10.3324/haematol.2019.235804. [Epub ahead of print] No abstract available.

3.

Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy.

Milgrom SA, Varghese B, Gladish GW, Choi AD, Dong W, Patel ZS, Chung CC, Rao A, Pinnix CC, Gunther JR, Dabaja BS, Lin SH, Hoffman KE, Huff JL, Slagowski J, Abe JI, Iliescu CA, Banchs J, Yusuf SW, Lopez-Mattei JC.

J Cardiovasc Imaging. 2019 Oct;27(4):268-279. doi: 10.4250/jcvi.2019.27.e38.

4.

Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function.

Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Lee HJ, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC.

Leuk Lymphoma. 2020 Jan;61(1):171-175. doi: 10.1080/10428194.2019.1644333. Epub 2019 Aug 2. No abstract available.

PMID:
31373240
5.

Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma.

Ning MS, Pinnix CC, Chapman BV, Gunther JR, Milgrom SA, Khoury JD, Jain P, Chen WY, Oriabure ON, Badillo MR, Wang LM, Dabaja BS.

Blood Adv. 2019 Jul 9;3(13):2035-2039. doi: 10.1182/bloodadvances.2019030858.

6.

Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma.

Andraos TY, Ayoub Z, Nastoupil LJ, Milgrom SA, Pinnix CC, Ng SP, Gunther JR, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Dabaja BS.

Leuk Lymphoma. 2019 Dec;60(13):3258-3265. doi: 10.1080/10428194.2019.1627535. Epub 2019 Jun 24.

PMID:
31234671
7.

Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?

Elhammali A, Milgrom SA, Amini B, Gunther JR, Yoder A, Ludmir EB, Moon B, Weber DM, Thomas SK, Garg N, Manasanch EE, Patel KK, Orlowski RZ, Lee HC, Bird JE, Satcher R, Lin P, Pinnix CC, Dabaja BS.

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e465-e469. doi: 10.1016/j.clml.2019.04.015. Epub 2019 May 2.

PMID:
31133526
8.

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma.

Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS.

Blood Adv. 2019 May 14;3(9):1356-1367. doi: 10.1182/bloodadvances.2018029140.

9.

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Yehia Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B.

Head Neck. 2019 May;41(5):1546. doi: 10.1002/hed.25738. Epub 2019 Mar 19. No abstract available.

PMID:
30990235
10.

Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy.

Ayoub Z, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS, Ng SP, Gunther JR, Khoury JD, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Nastoupil LJ.

Leuk Lymphoma. 2019 Oct;60(10):2432-2440. doi: 10.1080/10428194.2019.1597081. Epub 2019 Apr 3.

PMID:
30942648
11.

Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.

Andraos T, Ayoub Z, Nastoupil L, Pinnix C, Milgrom S, Gunther J, Ng SP, Fowler N, Neelapu S, Samaniego F, Dabaja B.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):381-389. doi: 10.1016/j.clml.2019.02.011. Epub 2019 Feb 26.

PMID:
30935940
12.

Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.

An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS.

Radiother Oncol. 2019 Feb;131:88-92. doi: 10.1016/j.radonc.2018.12.003. Epub 2018 Dec 31.

13.

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.

Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee HJ, Westin J, Fowler N, Nastoupil L, Dabaja B.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):447-455. doi: 10.1016/j.ijrobp.2019.02.002. Epub 2019 Feb 12.

PMID:
30769175
14.

The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).

Mikhaeel NG, Milgrom SA, Terezakis S, Berthelsen AK, Hodgson D, Eich HT, Dieckmann K, Qi SN, Yahalom J, Specht L.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):501-512. doi: 10.1016/j.ijrobp.2019.02.001. Epub 2019 Feb 11. Review.

PMID:
30763664
15.

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma.

Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL.

Sci Rep. 2019 Feb 4;9(1):1322. doi: 10.1038/s41598-018-37197-z.

16.

Rainbow IMRT and Volumetric Imaging for Anterior Mesenteric Targets.

Yoder AK, Gunther JR, Milgrom SA, Pham M, Hancock D, McSpadden K, Garcia J, Mirkovic D, Dabaja BS, Pinnix CC.

Pract Radiat Oncol. 2019 May;9(3):147-152. doi: 10.1016/j.prro.2019.01.007. Epub 2019 Jan 29. No abstract available.

PMID:
30708131
17.

Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.

Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ.

Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):244-250. doi: 10.1016/j.clml.2018.12.016. Epub 2019 Jan 3.

PMID:
30686775
18.

Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms.

Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA.

Onco Targets Ther. 2018 Dec 10;11:8937-8942. doi: 10.2147/OTT.S159843. eCollection 2018.

19.

Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement.

Jensen GL, Dabaja BS, Pinnix CC, Gunther JR, Huen A, Duvic M, Oki Y, Fanale M, Hosing C, Milgrom SA.

Case Rep Oncol. 2018 Nov 12;11(3):721-728. doi: 10.1159/000494081. eCollection 2018 Sep-Dec.

20.

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.

Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC.

Adv Radiat Oncol. 2018 Jul 12;3(4):639-646. doi: 10.1016/j.adro.2018.07.001. eCollection 2018 Oct-Dec.

Supplemental Content

Loading ...
Support Center